Verastem (VSTM)
(Delayed Data from NSDQ)
$11.80 USD
-0.02 (-0.17%)
Updated Mar 28, 2024 04:00 PM ET
After-Market: $11.79 -0.01 (-0.08%) 7:58 PM ET
4-Sell of 5 4
F Value F Growth D Momentum F VGM
Fundamental Charts
About PEG Ratio (TTM)
The company's trailing twelve month (TTM) PEG ratio is the P/E ratio divided by its long-term growth rate consensus. This ratio essentially compares the P/E to its growth rate, thus, for many, telling a more complete story than just the P/E ratio alone. Conventional wisdom says that a PEG ratio of 1 or less is considered good (at par or undervalued to its growth rate). A value greater than 1, in general, is not as good (overvalued to its growth rate). For example, a company with a P/E ratio of 25 and a growth rate of 20% would have a PEG ratio of 1.25 (25 / 20 = 1.25). A company with a P/E ratio of 40 and a growth rate of 50% would have a PEG ratio of 0.80 (40 / 50 = 0.80). Traditionally, investors would look at the stock with the lower P/E and deem it a bargain. But when compared to its growth rate, it doesn't have the earnings growth to justify its P/E. In this example, the one with the P/E of 40 is the better bargain because it is selling at a discount to its growth rate. So the PEG ratio tells you what you're paying for each unit of earnings growth.
VSTM 11.80 -0.02(-0.17%)
Will VSTM be a Portfolio Killer in March?
Zacks Investment Research is releasing its prediction for VSTM based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for VSTM
Verastem (VSTM) Up 8% on Fast Track Tag for NSCLC Combo Therapy
All You Need to Know About Verastem (VSTM) Rating Upgrade to Buy
VSTM: What are Zacks experts saying now?
Zacks Private Portfolio Services
Novo Nordisk (NVO) to Report Q2 Earnings: What's in the Cards?
Verastem (VSTM) Upgraded to Strong Buy: What Does It Mean for the Stock?
Precision BioSciences (DTIL) Reports Q1 Loss, Misses Revenue Estimates
Other News for VSTM
Catalyst Watch: Tesla deliveries, Disney board vote, DJT drama and Fortinet event
Verastem’s Strategic Advancements and Financial Stability Underscore Buy Rating
Earnings week ahead: Walgreens Boots Alliance, Carnival, GameStop and more
Verastem: Financial Resilience and Promising Drug Pipeline Despite Short-Term Losses
Global Patient Survey Results Reveal Significant Negative Impact on Social, Emotional and Mental Well-Being for People Living with Low-Grade Serous Ovarian Cancer